Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hedrick

Showing results (221-230 of 237) with videos related to

Pageof 24
Sort By:
Bioorganic & Medicinal Chemistry|June 12, 2002
10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathwayThomas H Marsilje, Marc A Labroli, Michael P Hedrick, et al.
Journal of Medicinal Chemistry|August 8, 2019
Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric ModulatorsAnthony B Pinkerton, Satyamaheshwar Peddibhotla, Fusayo Yamamoto, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Imidazole-derived agonists for the neurotensin 1 receptorPaul M Hershberger, Michael P Hedrick, Satyamaheshwar Peddibhotla, et al.
JAMA Network Open|July 10, 2020
Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicAhmad Jabri, Ankur Kalra, Ashish Kumar, et al.
Anatomical Record (Hoboken, N.J. : 2007)|November 23, 2023
Cochlea development shapes bat sensory system evolutionNeal Anthwal, Ronald P Hall, Frederick Aneudy de la Rosa Hernandez, et al.
Journal of Medicinal Chemistry|April 29, 2021
Discovery of Orally Bioavailable Purine-Based Inhibitors of the Low-Molecular-Weight Protein Tyrosine PhosphataseStephanie M Stanford, Michael A Diaz, Robert J Ardecky, et al.
The Journal of Eukaryotic Microbiology|July 18, 2001
Recent advances in our knowledge of the MyxozoaM L Kent, K B Andree, J L Bartholomew, et al.
ACS Chemical Biology|April 28, 2016
ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine AbuseLarry S Barak, Yushi Bai, Sean Peterson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2019
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLCTriparna Sen, Carminia M Della Corte, Snezana Milutinovic, et al.
SLAS Discovery : Advancing Life Sciences R & D|October 9, 2022
Development and use of a high-throughput screen to identify novel modulators of the corticotropin releasing factor binding proteinCarolina L Haass-Koffler, T Chase Francis, Pauravi Gandhi, et al.
Pageof 24

Showing results (221-230 of 237) with videos related to

Sort By:
Pageof 24
Bioorganic & Medicinal Chemistry|June 12, 2002
10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathwayThomas H Marsilje, Marc A Labroli, Michael P Hedrick, et al.
Journal of Medicinal Chemistry|August 8, 2019
Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric ModulatorsAnthony B Pinkerton, Satyamaheshwar Peddibhotla, Fusayo Yamamoto, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Imidazole-derived agonists for the neurotensin 1 receptorPaul M Hershberger, Michael P Hedrick, Satyamaheshwar Peddibhotla, et al.
JAMA Network Open|July 10, 2020
Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicAhmad Jabri, Ankur Kalra, Ashish Kumar, et al.
Anatomical Record (Hoboken, N.J. : 2007)|November 23, 2023
Cochlea development shapes bat sensory system evolutionNeal Anthwal, Ronald P Hall, Frederick Aneudy de la Rosa Hernandez, et al.
Journal of Medicinal Chemistry|April 29, 2021
Discovery of Orally Bioavailable Purine-Based Inhibitors of the Low-Molecular-Weight Protein Tyrosine PhosphataseStephanie M Stanford, Michael A Diaz, Robert J Ardecky, et al.
The Journal of Eukaryotic Microbiology|July 18, 2001
Recent advances in our knowledge of the MyxozoaM L Kent, K B Andree, J L Bartholomew, et al.
ACS Chemical Biology|April 28, 2016
ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine AbuseLarry S Barak, Yushi Bai, Sean Peterson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2019
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLCTriparna Sen, Carminia M Della Corte, Snezana Milutinovic, et al.
SLAS Discovery : Advancing Life Sciences R & D|October 9, 2022
Development and use of a high-throughput screen to identify novel modulators of the corticotropin releasing factor binding proteinCarolina L Haass-Koffler, T Chase Francis, Pauravi Gandhi, et al.
Pageof 24